|
Name |
1,2-Bis(p-(cis-styryl)phenyl)-trans-ethylene
|
Molecular Formula | C30H24 | |
IUPAC Name* |
1-[(Z)-2-phenylethenyl]-4-[(E)-2-[4-[(Z)-2-phenylethenyl]phenyl]ethenyl]benzene
|
|
SMILES |
C1=CC=C(C=C1)/C=C\C2=CC=C(C=C2)/C=C/C3=CC=C(C=C3)/C=C\C4=CC=CC=C4
|
|
InChI |
InChI=1S/C30H24/c1-3-7-25(8-4-1)11-13-27-15-19-29(20-16-27)23-24-30-21-17-28(18-22-30)14-12-26-9-5-2-6-10-26/h1-24H/b13-11-,14-12-,24-23+
|
|
InChIKey |
DXQFGTYOUGMXMH-JFSXGQESSA-N
|
|
Synonyms |
(E)-4,4'-Bis[(Z)-styryl]stilbene; 1,2-Bis(p-(cis-styryl)phenyl)-trans-ethylene; 1-[(Z)-2-Phenylethenyl]-4-((E)-2-(4-[(Z)-2-phenylethenyl]phenyl)ethenyl)benzene #
|
|
CAS | NA | |
PubChem CID | 5379644 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 384.5 | ALogp: | 9.3 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 30 | QED Weighted: | 0.277 |
Caco-2 Permeability: | -4.948 | MDCK Permeability: | 0.00000920 |
Pgp-inhibitor: | 0.996 | Pgp-substrate: | 0.005 |
Human Intestinal Absorption (HIA): | 0.11 | 20% Bioavailability (F20%): | 0.987 |
30% Bioavailability (F30%): | 0.278 |
Blood-Brain-Barrier Penetration (BBB): | 0.079 | Plasma Protein Binding (PPB): | 101.62% |
Volume Distribution (VD): | 0.251 | Fu: | 0.41% |
CYP1A2-inhibitor: | 0.758 | CYP1A2-substrate: | 0.063 |
CYP2C19-inhibitor: | 0.235 | CYP2C19-substrate: | 0.062 |
CYP2C9-inhibitor: | 0.098 | CYP2C9-substrate: | 0.001 |
CYP2D6-inhibitor: | 0.011 | CYP2D6-substrate: | 0.031 |
CYP3A4-inhibitor: | 0.174 | CYP3A4-substrate: | 0.411 |
Clearance (CL): | 10.116 | Half-life (T1/2): | 0.063 |
hERG Blockers: | 0.184 | Human Hepatotoxicity (H-HT): | 0.438 |
Drug-inuced Liver Injury (DILI): | 0.977 | AMES Toxicity: | 0.89 |
Rat Oral Acute Toxicity: | 0.248 | Maximum Recommended Daily Dose: | 0.368 |
Skin Sensitization: | 0.877 | Carcinogencity: | 0.799 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.931 |
Respiratory Toxicity: | 0.006 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000801 | 0.396 | D00HPK | 0.348 | ||||
ENC001456 | 0.384 | D0AA2D | 0.339 | ||||
ENC000894 | 0.339 | D0Q3YO | 0.328 | ||||
ENC001018 | 0.330 | D09GOS | 0.312 | ||||
ENC001523 | 0.324 | D01VMO | 0.307 | ||||
ENC005492 | 0.318 | D05CEU | 0.299 | ||||
ENC001737 | 0.315 | D02CTS | 0.290 | ||||
ENC001428 | 0.311 | D07KSG | 0.286 | ||||
ENC000891 | 0.295 | D0U3ED | 0.280 | ||||
ENC001402 | 0.293 | D0VU2X | 0.280 |